Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A F List

Showing results (71-80 of 96) with videos related to

Pageof 10
Sort By:
Leukemia|December 10, 2015
Extended survival and reduced risk of AML progression in erythroid-responsive lenalidomide-treated patients with lower-risk del(5q) MDSA F List, J M Bennett, M A Sekeres, et al.
Annals of Internal Medicine|November 1, 1986
Non-Hodgkin's lymphoma after treatment of Hodgkin's disease: association with Epstein-Barr virusA F List, J P Greer, J B Cousar, et al.
Leukemia|July 12, 2017
Intrapatient functional clonality deconvoluted by coupling intracellular flow cytometry and next-generation sequencing in human leukemiaQ Zhang, M C Ball, Y Zhao, et al.
Science (New York, N.Y.)|February 12, 1993
Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasiaC L Willman, C E Sever, M G Pallavicini, et al.
Leukemia|October 20, 2023
RAS-pathway mutations are common in patients with ruxolitinib refractory/intolerant myelofibrosis: molecular analysis of the PAC203 cohortJ M O'Sullivan, J Taylor, A Gerds, et al.
Leukemia|February 16, 2007
Prevalence and clinical association of clonal T-cell expansions in Myelodysplastic SyndromeP K Epling-Burnette, J S Painter, D E Rollison, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2001
Phase I/II study of the P-glycoprotein modulator PSC 833 in patients with acute myeloid leukemiaR Dorr, C Karanes, C Spier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1988
Non-Hodgkin's lymphoma of the gastrointestinal tract: an analysis of clinical and pathologic features affecting outcomeA F List, J P Greer, J C Cousar, et al.
Blood Cancer Journal|August 30, 2014
Validation of the IPSS-R in lenalidomide-treated, lower-risk myelodysplastic syndrome patients with del(5q)M A Sekeres, A S Swern, P Fenaux, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 11, 2004
Epigenomic changes during leukemia cell differentiation: analysis of histone acetylation and cytosine methylation using CpG island microarraysM Nouzova, N Holtan, M M Oshiro, et al.
Pageof 10

Showing results (71-80 of 96) with videos related to

Sort By:
Pageof 10
Leukemia|December 10, 2015
Extended survival and reduced risk of AML progression in erythroid-responsive lenalidomide-treated patients with lower-risk del(5q) MDSA F List, J M Bennett, M A Sekeres, et al.
Annals of Internal Medicine|November 1, 1986
Non-Hodgkin's lymphoma after treatment of Hodgkin's disease: association with Epstein-Barr virusA F List, J P Greer, J B Cousar, et al.
Leukemia|July 12, 2017
Intrapatient functional clonality deconvoluted by coupling intracellular flow cytometry and next-generation sequencing in human leukemiaQ Zhang, M C Ball, Y Zhao, et al.
Science (New York, N.Y.)|February 12, 1993
Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasiaC L Willman, C E Sever, M G Pallavicini, et al.
Leukemia|October 20, 2023
RAS-pathway mutations are common in patients with ruxolitinib refractory/intolerant myelofibrosis: molecular analysis of the PAC203 cohortJ M O'Sullivan, J Taylor, A Gerds, et al.
Leukemia|February 16, 2007
Prevalence and clinical association of clonal T-cell expansions in Myelodysplastic SyndromeP K Epling-Burnette, J S Painter, D E Rollison, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2001
Phase I/II study of the P-glycoprotein modulator PSC 833 in patients with acute myeloid leukemiaR Dorr, C Karanes, C Spier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1988
Non-Hodgkin's lymphoma of the gastrointestinal tract: an analysis of clinical and pathologic features affecting outcomeA F List, J P Greer, J C Cousar, et al.
Blood Cancer Journal|August 30, 2014
Validation of the IPSS-R in lenalidomide-treated, lower-risk myelodysplastic syndrome patients with del(5q)M A Sekeres, A S Swern, P Fenaux, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 11, 2004
Epigenomic changes during leukemia cell differentiation: analysis of histone acetylation and cytosine methylation using CpG island microarraysM Nouzova, N Holtan, M M Oshiro, et al.
Pageof 10